STAT+: Pharmalittle: AstraZeneca says studies show its Covid-19 vaccine is 79% effective; rich countries created vaccine inequity

Good morning, everyone, and welcome to another working week. We hope the weekend respite was relaxing and invigorating, because that oh-so familiar routine of Zoom meetings, Skype calls, and deadlines has predictably returned. But what can you do? The world, such as it is, keeps spinning. So we will give it a nudge with a delicious cup of stimulation. Our choice today is original glazed doughnut. Yum. Please feel free to join us. Meanwhile, here are some tidbits to get you going. We hope your day is successful, and do stay safe — wear a mask. …

AstraZeneca (AZN) reported that its Covid-19 vaccine was safe and 79% effective in preventing symptomatic disease in U.S. clinical trials involving more than 32,000 people, STAT writes. The move paves the way for likely authorization in the U.S. The studies showed the vaccine reduced severe Covid-19 and hospitalization by 100%, and that the vaccine was equally effective in people over 65, where it had 80% efficacy. The company also maintained it did not identify any new safety concerns.

Continue to STAT+ to read the full story…

STAT+: Pharmalittle: AstraZeneca says studies show its Covid-19 vaccine is 79% effective; rich countries created vaccine inequity

Leave a Reply

Your email address will not be published. Required fields are marked *

Scroll to top